P

Personalis

Specialized cancer genomics sequencing and analysis

Senior Bioinformatics Scientist - Collaborations

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeFremont, CA, USA$158k - $190k /yr

About the Job

Requirements

  • An advanced degree (Ph.D.) in bioinformatics, genomics, or a related field.
  • Experience managing, analyzing, and interpreting large, impactful multi-participant projects.
  • Experience with cancer liquid biopsy analysis.
  • Experience with survival analysis.
  • Proficiency with at least one common programming language, such as Python or R.
  • Experience with cancer genomics and variant detection.
  • Experience publishing and presenting scientific results.

Responsibilities

  • Plan, develop, and manage scientific collaborations, applying internally developed liquid biopsy and solid tumor products to detect somatic variants, neoantigens, and tumor escape mechanisms within high-profile and impactful partnerships.
  • Build upon novel cell-free platforms and products, including the NeXT Personal MRD liquid biopsy platform.
  • Work cross-functionally to translate collaborative findings into actively developed products.
  • Design and execute scientific projects and experiments focused on demonstrating the performance, research advantages, and clinical advantages of cell-free platforms.
  • Model and analyze large, complex genomics datasets using cutting-edge methods to generate biological and clinical insights.
  • Work with scientific teams to translate scientific findings into actively developed products.
  • Publish results and present at conferences in areas including cell-free DNA, cancer genomics, and immuno-oncology.

About the Company

Personalis

Specialized cancer genomics sequencing and analysis

Personalis provides cancer genomics services, including sequencing and data analysis, to support biotech R&D and precision oncology. Its NeXT Platform analyzes a single tissue sample to generate comprehensive molecular data across about 20,000 human genes, covering tumor and immune features. A key product, NeXT Personal, is an ultra-sensitive assay that detects minimal residual disease and cancer recurrence by measuring circulating tumor DNA to guide ongoing patient care. The company differentiates itself with integrated sequencing and analytics at gene-scale from one sample and a focus on MRD and immuno-oncology biomarkers, aiming to bring data-driven, personalized cancer treatment and monitoring into clinical use.

Company size
201-500
Company stage
IPO
Headquarters
Menlo Park, CA
Founded
2011

Recently Posted Jobs

Explore more opportunities at Personalis

See more jobs